Header image

7B: Collaborative Centre for Cardiometabolic Health in Psychosis (ccCHiP): Integrating traditional healthcare services to meet the needs of the mental health population (Workshop)

Tracks
Track 2
Tuesday, November 12, 2019
12:30 PM - 1:30 PM
Room 101 - 102

Details

Chaired by Professor Tim Lambert, Professor of Psychiatry, University of Sydney


Speaker

Agenda Item Image
Professor Tim Lambert
Professor of Psychiatry
University of Sydney

41 Collaborative Centre for Cardiometabolic Health in Psychosis (ccCHiP): Integrating traditional healthcare services to meet the needs of the mental health population

Abstract

Background: Rates of cardiovascular disease and its related co-morbidities in those with severe mental illness are disproportionately high. Those suffering from a severe mental illness are six times more likely to die from cardiovascular disease and overall likely to die 14-23 years earlier than the general population (Australian National Mental Health Commission, 2017). The Collaborative Centre for Cardiometabolic Health in Psychosis (ccCHiP) is a joint initiative between Sydney Local Health District, Sydney University and Concord Hospital. ccCHiP delivers an award-winning innovative service that provides a model of integrated care for the assessment and management of cardiometabolic health in those with a severe and enduring mental illness to reduce the disparity in life expectancy between the mental health and general population.
Using a ‘one-stop-shop’ model, ccCHiP integrates multiple services and clinicians to provide a clinic in one afternoon to improve accessibility to a population who would otherwise have engagement and adherence challenges whilst bridging ‘traditional service delivery models’. This includes the collaborative efforts between a psychiatrist, cardiologist, endocrinologist, exercise physiologist, dietician, nurse, dentist and sleep medicine.
Aim: The aim of this workshop is to introduce attendees to clinical and service delivery of a patient-centered integrated care model for people with severe mental illness who have multimorbidity. Experienced members of the ccCHiP team will showcase the ccCHiP model through the use of a simulated clinic using ccCHiP staff and actors. We will also demonstrate the innovative informatics system developed and successfully implemented by ccCHiP for integrated health settings.
Objectives: To provide improved knowledge for workshop attendees on the disproportionately poor health outcomes of people with severe mental illness (SMI) and skills with respect to their management of cardiometabolic comorbidities. Moreover, to provide inspiration to translate the knowledge, confidence and skills acquired by attendees, to consider developing similar models of care in their own services or health districts and other disciplines of medicine.
Target audience: Attendees from a diverse range of clinical and non-clinical backgrounds, academics and community care professionals.
Learning/Take away: An integrated care approach can be the way to bridge traditional service delivery in order to meet the growing needs of a complex cohort; appropriate training and education can alleviate resistance to change and technology can assist these processes.
Format: The workshop will consist of six simulation-based clinic sessions providing an overview of the ccCHiP model of care. Speakers from each of the six disciplines of dietetics, exercise physiology, cardiology/endocrinology, psychiatry, dentistry and a sleep medicine will essentially simulate the ccCHiP clinic process. Each of these sessions will take 7-10 minutes. This will be followed by interactive group exercises and audience discussion led by an experienced facilitator. Attendees will be seated at tables and provided with questions and discussion points – a team member will also be present to aid the discussion about the model. This will create opportunities for attendees to reflect on the process of the integrated, multidisciplinary approach; its benefits for patient care and how this model could be used in their setting.

Biography

Tim Lambert is Professor of Psychiatry at Concord Clinical School at The University of Sydney in Australia. He is the clinical and academic director of the Collaborative Centre for Cardiometabolic Health in Psychosis (ccCHiP). Professor Lambert has spent 25 years researching, teaching and providing clinical services in the area of schizophrenia and other psychotic disorders with a particular emphasis on treatments and outcomes. He has a portfolio of interests in translational aspects of clinical neuropharmacology and neurosciences spanning clinical psychosis research, outcomes research, service delivery models, clinical training, and multimedia-based education. His primary focus at present is on the development of integrated models of care for chronic multisystem comorbidity in persons with severe psychotic disorders. As a long-standing clinical psychopharmacologist Prof Lambert maintains his interests in the following areas: • services research (pharmacoepidemiology, developing novel relapse prevention services such as CERP, treatment resistance programmes and determinants of long-stay patient populations, and cardiometabolic services for the seriously mentally ill); • the clinical pharmacology of long acting antipsychotics (LAIs) antipsychotics (first and second generation); • risk-benefit aspects and the applied clinical pharmacology of antipsychotic switching; • incomplete recovery (aka treatment resistance and resistance to treatment). Social aspects, particularly the role of acculturation on clinical phenotypes, permeate all facets of these programmes. In terms of education and training, his team has been developing new media-based approaches to education and this work has been utilized to produce educational and training materials such as CD-ROMs, DVDs and web-based applications for mental health workers in many parts of the world. He has been a principal in the development of a number of clinical practice guidelines, algorithms, and consensus documents (Diabetes and antipsychotics; RANZCP CPG for schizophrenia; Treatment Refractory and Clozapine Consensus Guidelines, RANZCP guidelines for physical comorbidity in psychotic disorders, for example). Professor Lambert is a regularly invited lecturer, clinical trainer, and consultant throughout Asia, Australia, Europe, and North America. He has been a member of a number of international and national advisory groups concerned with antipsychotic treatments and their role in community psychiatry.
loading